Search Videos and More

Showing 25 - 36 of 590 results

Previous| 1... 2 | 3 | 4 ...50 |Next


Dana-Farber Research News 08.01.2025 News

Dana-Farber Research News 08.01.2025

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from July 1 through July 15.
Dana-Farber Research Shows Promise for Targeted Therapies for Pediatric Gliomas News

Dana-Farber Research Shows Promise for Targeted Therapies for Pediatric Gliomas

Results from this study show that already approved precision medicines have the potential benefit for children with FGFR-altered gliomas.
U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nation’s Best for 2025-2026 News

U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nation’s Best for 2025-2026

Recognition marks a quarter of a century of excellence
Study Paves Path to Improved Diagnosis, Treatment of NUT Carcinoma News

Study Paves Path to Improved Diagnosis, Treatment of NUT Carcinoma

Dana-Farber research uncovered the potential for underdiagnosis of this aggressive cancer and identified additional tests required for an accurate diagnosis.
Global Rise in Many Early-Onset GI Cancers Detailed in Two Dana-Farber Reviews, With Colorectal Cancer Leading the Trend News

Global Rise in Many Early-Onset GI Cancers Detailed in Two Dana-Farber Reviews, With Colorectal Cancer Leading the Trend

Early-onset gastrointestinal (GI) cancers are rising at alarming rates worldwide and, in the U.S., are increasing faster than any other type of early-onset cancer, including breast cancer, according to two recent literature reviews from Dana-Farber Cancer Institute.
Dana-Farber Research News 07.15.2025 News

Dana-Farber Research News 07.15.2025

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from June 16 through June 30.
TILs: What Are They and How Are They Used in Cancer Treatment? News

TILs: What Are They and How Are They Used in Cancer Treatment?

Tumor-infiltrating lymphocyte, or TIL, therapy uses a patient’s own immune system T cells to fight cancer.
Modified Personalized Cancer Vaccine Generates Powerful Immune Response News

Modified Personalized Cancer Vaccine Generates Powerful Immune Response

Dana-Farber researchers designed a novel formulation and delivery approach for the NeoVax personalized cancer vaccine and observed strong vaccine-specific immune responses in patients with melanoma.
Dana-Farber Report Shows Alarming Rise in Many Gastrointestinal Cancers in Young People News

Dana-Farber Report Shows Alarming Rise in Many Gastrointestinal Cancers in Young People

Dana-Farber experts report rising rates of colorectal, pancreatic, esophageal, and other less common GI cancers in people under 50 and point to important next steps.
Teen with Rare Sarcoma Enjoys Stellar Response on Clinical Trial News

Teen with Rare Sarcoma Enjoys Stellar Response on Clinical Trial

Like many teenagers, Isabella (Bella) Snow Fraser, 15, enjoys immersing herself in action role-play games online.
Tracing a Career of Unrelenting Discovery News

Tracing a Career of Unrelenting Discovery

Dr. Ben Ebert's Legacy of Collaborative Research Fuels Innovation at Dana-Farber
Dana-Farber Research News 07.01.2025 News

Dana-Farber Research News 07.01.2025

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from June 1 through June 15.

Showing 25 - 36 of 590 results

Previous| 1... 2 | 3 | 4 ...50 |Next